Teriparatide 750mcg/3ml (TERIFRAC)
Teriparatide 750mcg/3ml (TERIFRAC) is a highly effective treatment designed to strengthen bones and reduce the risk of fractures in patients with osteoporosis. This injectable medication works by stimulating new bone formation, making it ideal for individuals with severe bone loss or high fracture risk. It is commonly prescribed for postmenopausal women and men with osteoporosis. With consistent use under medical supervision, it enhances bone density and improves overall skeletal health. TERIFRAC offers a reliable and clinically proven solution to restore bone strength and support long-term mobility, helping patients lead a healthier and more active lifestyle
Description
Teriparatide 750mcg/3ml (TERIFRAC) offers an advanced and clinically proven solution for individuals suffering from osteoporosis and severe bone loss. This injectable medication actively stimulates new bone formation, helping the body rebuild stronger and healthier bones. Doctors prescribe this treatment to patients who face a high risk of fractures, especially postmenopausal women and men with weakened bone density.
This formulation works by mimicking the natural parathyroid hormone in the body, which regulates calcium metabolism and bone growth. By enhancing bone-building activity, it increases bone mass and improves skeletal strength. Regular use under medical supervision significantly reduces the chances of fractures in critical areas such as the spine and hips.
Healthcare professionals recommend this therapy for patients who do not respond well to other osteoporosis treatments or require a more aggressive approach to bone restoration. The easy-to-administer injection ensures convenience and supports consistent treatment adherence.
Patients benefit from improved mobility, reduced pain, and better overall quality of life as bone strength gradually increases. Maintaining proper dosage and following medical guidance ensures optimal results and minimizes potential side effects.
Store the injection in a refrigerator between 2°C and 8°C to maintain its effectiveness. Avoid freezing and protect it from direct light. Always handle the product carefully and use it as directed by a qualified healthcare provider.
Teriparatide 750mcg/3ml (TERIFRAC) empowers patients to take control of their bone health by promoting natural bone regeneration. With its targeted mechanism and reliable results, it stands as a trusted choice for managing osteoporosis and preventing fractures effectively.
- Product Name: TERIFRAC
- Generic Name: Teriparatide
- Strength: 750mcg/3ml
- Dosage Form: Injection
- Indication: Osteoporosis treatment
- Mechanism: Stimulates new bone formation
- Suitable For: Postmenopausal women and men with high fracture risk
- Administration: As prescribed by a healthcare professional
- Storage: Store in a refrigerator (2°C to 8°C), do not freeze
- Packaging: Pre-filled injection device
